Future directions in regulatory affairs
The field of regulatory affairs deals with the regulatory requirements for marketing authorization of therapeutic products. This field is facing a myriad of forces impacting all aspects of the development, regulation and value proposition of new therapeutic products. Changes in global megatrends, su...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1082384/full |
| _version_ | 1797957458392514560 |
|---|---|
| author | Orin Chisholm Helen Critchley |
| author_facet | Orin Chisholm Helen Critchley |
| author_sort | Orin Chisholm |
| collection | DOAJ |
| description | The field of regulatory affairs deals with the regulatory requirements for marketing authorization of therapeutic products. This field is facing a myriad of forces impacting all aspects of the development, regulation and value proposition of new therapeutic products. Changes in global megatrends, such as geopolitical shifts and the rise of the green economy, have emphasized the importance of manufacturing and supply chain security, and reducing the environmental impacts of product development. Rapid changes due to advances in science, digital disruption, a renewed focus on the centrality of the patient in all stages of therapeutic product development and greater collaboration between national regulatory authorities have been accelerated by the COVID-19 pandemic. This article will discuss the various trends that are impacting the development of new therapies for alleviating disease and how these trends therefore impact on the role of the regulatory affairs professional. We discuss some of the challenges and provide insights for the regulatory professional to remain at the forefront of these trends and prepare for their impacts on their work. |
| first_indexed | 2024-04-11T00:04:21Z |
| format | Article |
| id | doaj.art-60606f0c18a644f391bbf9e43718d072 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-11T00:04:21Z |
| publishDate | 2023-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-60606f0c18a644f391bbf9e43718d0722023-01-09T12:20:01ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-01-01910.3389/fmed.2022.10823841082384Future directions in regulatory affairsOrin Chisholm0Helen Critchley1Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Sydney, NSW, AustraliaSanofi, Macquarie Park, NSW, AustraliaThe field of regulatory affairs deals with the regulatory requirements for marketing authorization of therapeutic products. This field is facing a myriad of forces impacting all aspects of the development, regulation and value proposition of new therapeutic products. Changes in global megatrends, such as geopolitical shifts and the rise of the green economy, have emphasized the importance of manufacturing and supply chain security, and reducing the environmental impacts of product development. Rapid changes due to advances in science, digital disruption, a renewed focus on the centrality of the patient in all stages of therapeutic product development and greater collaboration between national regulatory authorities have been accelerated by the COVID-19 pandemic. This article will discuss the various trends that are impacting the development of new therapies for alleviating disease and how these trends therefore impact on the role of the regulatory affairs professional. We discuss some of the challenges and provide insights for the regulatory professional to remain at the forefront of these trends and prepare for their impacts on their work.https://www.frontiersin.org/articles/10.3389/fmed.2022.1082384/fullregulatory affairsregulatory sciencedrug developmentfuture trendsdigital disruptionskills |
| spellingShingle | Orin Chisholm Helen Critchley Future directions in regulatory affairs Frontiers in Medicine regulatory affairs regulatory science drug development future trends digital disruption skills |
| title | Future directions in regulatory affairs |
| title_full | Future directions in regulatory affairs |
| title_fullStr | Future directions in regulatory affairs |
| title_full_unstemmed | Future directions in regulatory affairs |
| title_short | Future directions in regulatory affairs |
| title_sort | future directions in regulatory affairs |
| topic | regulatory affairs regulatory science drug development future trends digital disruption skills |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.1082384/full |
| work_keys_str_mv | AT orinchisholm futuredirectionsinregulatoryaffairs AT helencritchley futuredirectionsinregulatoryaffairs |